Business ❯ Finance ❯ Corporate Actions

Stock Offerings

Amended Sales Agreement Lowball Offerings Canoo Sagimet Biosciences Offering Preferred Stock Valuation Capital Raising At-the-Market Offerings Funding Strategies

Sagimet Prices $175 Million Stock Offering as It Plans U.S. Phase 3 Acne Trial

The raise extends Sagimet’s cash runway to fund acne trials through 2028.

Strategy Buys 2,486 Bitcoin, Taking Holdings to 717,131 BTC as Funding Leans on Preferreds

Strive Files $150 Million SATA Preferred Offering to Add Bitcoin and Retire Semler Notes

Tether Halts Cut-Price Share Sale as It Pursues $20 Billion Raise at $500 Billion Valuation

Bakkt Launches $1 Billion Crypto Offering as Shares Drop 40% in Premarket